Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
Phase II multicenter,open-label, clinical and pharmacokinetic study of Aplidin® as a 3-hour infusion every 2 weeks, in patients with advanced or metastatic transitional cell carcinoma of the urothelium, relapsing or progressing after first line chemotherapy https://kusajili.com:443/Trial/X39A6HqTNkiDJ8xX8Ma36A%24phase-ii-multicenteropen-label-clinical-and-pharmacokinetic-study-of-aplidinr-as-a-3-hour-infusion-every-2-weeks-in-patients-wi
I have read and accept the terms of use of the site and the Privacy Policy
Send your message